Immune Regulation by Gadd45b and Gadd45g
Immune Regulation by Gadd45b and Gadd45g
批准号:
7545810
负责人:
Binfeng Lu
金额:
$30.16万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-01-01 至 2010-12-31
关键词:
AffectApoptosisApoptoticAutoimmune DiseasesAutoimmunityB-LymphocytesCD4 Positive T LymphocytesCellsClinicalComplexDataDevelopmentDiseaseDisease MarkerEffector CellEncephalomyelitisExperimental Autoimmune EncephalomyelitisFamilyFamily memberFlow CytometryG2/M TransitionGADD45GADD45A geneGADD45BGADD45B/GADD45GGADD45GGene FamilyGenesGrowthHistocytochemistryHomeostasisImmuneInfectionInterleukin-10Interleukin-12Interleukin-18KineticsLeadListeria monocytogenesLupusLymphoid TissueMAPK14 geneMediatingMitogen-Activated Protein KinasesModelingMolecularMultiple SclerosisMusPeripheralPhenotypePlayProtein FamilyRegulationRoleSignal TransductionSpleenSplenomegalyT-Cell ProliferationT-LymphocyteTestingTh1 CellsTransgenic OrganismsWild Type Mouseinsightmembermitogen-activated protein kinase p38mouse modelnovel strategiespreventresponse
中文摘要
我们的长期目标是了解控制自身免疫性疾病的分子机制。我们
目前的焦点是一个名为Gadd 45(生长停滞和DNA损伤诱导)的基因家族,
由三个成员组成,Gadd 45 a、Gadd 45 b和Gadd 45 g。Gadd 45 a被证明参与了
已知调节T细胞的体内平衡和缺乏Gadd 45 a会引起狼疮。另外两个的作用
家族成员Gadd 45 b和Gadd 45 g在自身免疫性疾病中的作用尚不清楚。在Th 1细胞中,Gadd 45 b和
Gadd 45 g,而不是Gadd 45 a,由TCP信号或IL-12和IL-18诱导。我们发现,缺乏
Gadd 45 b和Gadd 45 g导致针对单核细胞增多性李斯特菌的Th 1细胞数量急剧减少。
预期Th 1细胞数量较少,我们惊讶地看到Gadd 45 b缺失导致
实验性过敏性脑脊髓炎(EAE)加重,临床体征更严重,
病程和增加的自身反应性Th 1细胞在发炎的中枢神经系统。Gadd 45 b缺失也导致了
老年小鼠的脾脏肿大。Gadd 45 b/Gadd 45 g双缺陷进一步加重了这种表型,
与Gadd 45 b单一缺失相比,在老年小鼠中导致脾脏大大增大。的扩大
脾脏中的CD 4 + T细胞和B细胞的聚集是由于具有活化表型的CD 4 + T细胞和B细胞的聚集。我们的数据
提示Gadd 45 b和Gadd 45 g在调节活化CD 4 + T细胞中发挥协同作用。此外,本发明还提供了一种方法,
我们发现Gadd 45 b和Gadd 45 g抑制增殖,并且是活化的细胞凋亡所必需的。
CD 4 + T细胞。在这项提议中,我们正在测试Gadd 45蛋白家族成员Gadd 45 b
和Gadd 45 g是自身免疫的重要负性调节因子。具体来说,我们计划:1。提供明确
证明Gadd 45 b和Gadd 45 g协同调节自身免疫性疾病,2.确定Gadd 45 b和
Gadd 45 g在EAE中对T细胞增殖和凋亡的调控起关键作用。研究分子
Gadd 45 b和Gadd 45 g调控Th 1细胞增殖和凋亡的机制。调控
Gadd 45家族分子对外周效应CD 4 + T细胞增殖和凋亡的影响提供了一种新的研究方法。
自身免疫的新调节机制。
相关性:这项研究将导致针对这些分子的新策略的发展,以治疗或
预防自身免疫性疾病。这项研究还将揭示自身免疫性疾病的新疾病标志物。
英文摘要
Our long term objective is to understand the molecular mechanisms that control autoimmune diseases. Our
immediate focus is on a gene family called Gadd45 (growth-arrest and DNA damage-inducible) which
consists of three members,Gadd45a, Gadd45b, and Gadd45g. Gadd45a was shown to be involved in
regulating homeostasis of T cells and lack of Gadd45a was known to cause lupus. The role of the other two
family members, Gadd45b and Gadd45g, in autoimmune diseases is not clear. In Th1 cells, Gadd45b and
Gadd45g, but not Gadd45a, are induced by TCP signaling or IL-12 and IL-18. We have found that the lack of
Gadd45b and Gadd45g results in a drastically reduced number of Th1 cells against Listeria monocytogenes.
Expecting low numbers of Th1 cells, we were surprised to see that Gadd45b deletion resulted in
exacerbated experimental allergic encephalomyelitis (EAE) with more severe clinical signs, a prolonged
disease course and increased autoreactive Th1 cells in the inflamed CNS. Gadd45b deletion also resulted in
enlarged spleens in older mice. Gadd45b/Gadd45g double-deficiency further aggravated this phenotype and
resulted in greatly enlarged spleens in older mice compared to Gadd45b single deletion. The enlargement of
spleens was due to the accumulation of CD4+ T cells with an activated phenotype and B cells. Our data
suggest that Gadd45b and Gadd45g play a synergistic role in regulating activated CD4+ T cells. In addition,
we found that Gadd45b and Gadd45g inhibited proliferation and were required for apoptosis of activated
CD4+ T cells. In this proposal we are testing the hypothesis that Gadd45 protein family members Gadd45b
and Gadd45g are important negative regulators of autoimmunity. Specifically we plan to: 1. provide definitive
proof that Gadd45b and Gadd45g coordinately regulate autoimmune diseases, 2. determine if Gadd45b and
Gadd45g are critical for the control of T cell proliferation and apoptosis in EAE, and 3. study molecular
mechanisms that regulate the proliferation and apoptosis of Th1 cells by Gadd45b and Gadd45g. Regulation
of proliferation and apoptosis in peripheral effector CD4+ T cells by Gadd45 family of molecules provides a
new regulatory mechanism for autoimmunity.
Relevance: This study will lead to the development of novel strategies targeting these molecules to treat or
prevent autoimmune diseases. This study will also reveal new disease markers for autoimmune diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy
-
批准号:10703824
-
项目类别:
-
资助金额:$24.42万
-
财政年份:2022
-
负责人:Binfeng Lu
-
依托单位:
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy
-
批准号:10625415
-
项目类别:
-
资助金额:$39.31万
-
财政年份:2022
-
负责人:Binfeng Lu
-
依托单位:
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy
-
批准号:10431979
-
项目类别:
-
资助金额:$13.3万
-
财政年份:2021
-
负责人:Binfeng Lu
-
依托单位:
Dissecting the role of the ATF4 stress response in T cell-mediated inflammation
-
批准号:9240576
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2016
-
负责人:Binfeng Lu
-
依托单位:
Cellular and molecular mechanisms underlying IL-33-mediated anti-tumor immunity
-
批准号:8443458
-
项目类别:
-
资助金额:$16.58万
-
财政年份:2013
-
负责人:Binfeng Lu
-
依托单位:
Cellular and molecular mechanisms underlying IL-33-mediated anti-tumor immunity
-
批准号:8602513
-
项目类别:
-
资助金额:$19.4万
-
财政年份:2013
-
负责人:Binfeng Lu
-
依托单位:
Immune Regulation by Gadd45b and Gadd45g
-
批准号:7330322
-
项目类别:
-
资助金额:$30.16万
-
财政年份:2006
-
负责人:Binfeng Lu
-
依托单位:
Immune Regulation by Gadd45b and Gadd45g
-
批准号:7031286
-
项目类别:
-
资助金额:$31.67万
-
财政年份:2006
-
负责人:Binfeng Lu
-
依托单位:
Immune Regulation by Gadd45b and Gadd45g
-
批准号:7162073
-
项目类别:
-
资助金额:$30.75万
-
财政年份:2006
-
负责人:Binfeng Lu
-
依托单位:
Immune Regulation by Gadd45b and Gadd45g
-
批准号:7746479
-
项目类别:
-
资助金额:$29.86万
-
财政年份:2006
-
负责人:Binfeng Lu
-
依托单位:
Regulation of the MAP kinase pathway in the CD4+ T cells
-
批准号:7216788
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2003
-
负责人:Binfeng Lu
-
依托单位:
Regulation of the MAP kinase pathway in the CD4+ T cells
-
批准号:7055357
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2003
-
负责人:Binfeng Lu
-
依托单位:
Regulation of the MAP kinase pathway in the CD4+ T cells
-
批准号:6766894
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2003
-
负责人:Binfeng Lu
-
依托单位:
Regulation of the MAP kinase pathway in the CD4+ T cells
-
批准号:6879128
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2003
-
负责人:Binfeng Lu
-
依托单位:
Regulation of the MAP kinase pathway in the CD4+ T cells
-
批准号:6614073
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2003
-
负责人:Binfeng Lu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: